close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

1,042.17

-0.56%↓

JNJ

210.98

+0.88%↑

ABBV

224.84

+0.63%↑

UNH

331.47

-0.62%↓

AZN

90.05

-1.5%↓

LLY

1,042.17

-0.56%↓

JNJ

210.98

+0.88%↑

ABBV

224.84

+0.63%↑

UNH

331.47

-0.62%↓

AZN

90.05

-1.5%↓

LLY

1,042.17

-0.56%↓

JNJ

210.98

+0.88%↑

ABBV

224.84

+0.63%↑

UNH

331.47

-0.62%↓

AZN

90.05

-1.5%↓

LLY

1,042.17

-0.56%↓

JNJ

210.98

+0.88%↑

ABBV

224.84

+0.63%↑

UNH

331.47

-0.62%↓

AZN

90.05

-1.5%↓

LLY

1,042.17

-0.56%↓

JNJ

210.98

+0.88%↑

ABBV

224.84

+0.63%↑

UNH

331.47

-0.62%↓

AZN

90.05

-1.5%↓

Home・Aandelen Lijst・Pulse Biosciences Inc
Search

Pulse Biosciences Inc

Gesloten

SectorGezondheidszorg

14.26 0.07

Buy

Prijsupdate 17 dec 2025, 20:59 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

13.9

Max

14.35

Belangrijke statistieken

By Trading Economics

Inkomsten

-217K

-19M

Verkoop

86K

86K

EPS

-0.29

Winstmarge

-22,540.698

Werknemers

75

EBITDA

-228K

-19M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+54.6% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-179M

958M

Vorige openingsprijs

14.19

Vorige sluitingsprijs

14.26

Nieuwssentiment

By Acuity

34%

66%

97 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

16.59 / 17.17 Steun & Weerstand

Pulse Biosciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

16 dec 2025, 23:46 UTC

Marktinformatie

Gold Edges Higher, Aided by Fed Rate-Cut Prospects -- Market Talk

DJ

Lezen

16 dec 2025, 23:38 UTC

Marktinformatie

Nikkei May Rise on Possible Bargain-Hunting Interest -- Market Talk

DJ

Lezen

16 dec 2025, 22:35 UTC

Acquisities, Fusies, Overnames

Santos: Sale Delivered Cash, Reduced Future Decommissioning Exposure

DJ

Lezen

16 dec 2025, 22:35 UTC

Acquisities, Fusies, Overnames

Santos Sold 43% Stake in Petrel Fields, 100% of Tern Fields to Eni Australia

DJ

Lezen

16 dec 2025, 22:33 UTC

Acquisities, Fusies, Overnames

Santos: A$40M Upfront Consideration, Up to A$20M in Contingent Payments

DJ

Lezen

16 dec 2025, 22:33 UTC

Acquisities, Fusies, Overnames

Santos Sold 43% Operated Interest in Mahalo JV to Comet Ridge

DJ

Lezen

16 dec 2025, 22:32 UTC

Acquisities, Fusies, Overnames

Santos Divests Two Noncore Assets as Part of Portfolio Optimization

DJ

Lezen

16 dec 2025, 22:25 UTC

Acquisities, Fusies, Overnames

Westgold's Indicative Timetable Points to Early February Completion

DJ

Lezen

16 dec 2025, 22:24 UTC

Acquisities, Fusies, Overnames

Westgold: Divestment Aligns With Broader Corporate Strategy

DJ

Lezen

16 dec 2025, 22:23 UTC

Acquisities, Fusies, Overnames

Westgold: Deferred Payment Based on Performance Hurdles

DJ

Lezen

16 dec 2025, 22:23 UTC

Acquisities, Fusies, Overnames

Westgold Will Receive A$15M Cash, A$19.6M in Alicanto Shares

DJ

Lezen

16 dec 2025, 22:23 UTC

Acquisities, Fusies, Overnames

Westgold to Receive A$30M Deferred Payment in Cash or Shares

DJ

Lezen

16 dec 2025, 22:22 UTC

Acquisities, Fusies, Overnames

Westgold Divesting Noncore Operating Asset for A$64.6M

DJ

Lezen

16 dec 2025, 22:22 UTC

Acquisities, Fusies, Overnames

Westgold Agrees to Sell Mt Henry-Selene Project to Alicanto Minerals

DJ

Lezen

16 dec 2025, 21:53 UTC

Winsten

Lennar Misses Earnings Estimates. The Stock Is Dropping. -- Barrons.com

DJ

Lezen

16 dec 2025, 21:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

DJ

Lezen

16 dec 2025, 21:33 UTC

Acquisities, Fusies, Overnames

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- 2nd Update

DJ

Lezen

16 dec 2025, 21:18 UTC

Acquisities, Fusies, Overnames

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- Update

DJ

Lezen

16 dec 2025, 21:17 UTC

Acquisities, Fusies, Overnames

Worthington Enterprises to Buy LSI Group for About $205M >WOR

DJ

Lezen

16 dec 2025, 21:16 UTC

Winsten

Worthington Enterprises 2Q Sales $327.5M >WOR

DJ

Lezen

16 dec 2025, 21:16 UTC

Winsten

Worthington Enterprises 2Q Adj EPS 65c >WOR

DJ

Lezen

16 dec 2025, 21:16 UTC

Winsten

Worthington Enterprises 2Q EPS 55c >WOR

DJ

Lezen

16 dec 2025, 21:15 UTC

Acquisities, Fusies, Overnames

Worthington Enterprises Agrees To Acquire Leading Metal Roof Components Manufacturer LSI Group >WOR

DJ

Lezen

16 dec 2025, 21:05 UTC

Acquisities, Fusies, Overnames

Ecolab Closes Acquisition Of Ovivo's Electronics Ultrapure Water Business >ECL

DJ

Lezen

16 dec 2025, 20:54 UTC

Acquisities, Fusies, Overnames

Warner to Reject Paramount Offer As Soon As Wednesday, Sources Say -- WSJ

DJ

Lezen

16 dec 2025, 20:54 UTC

Acquisities, Fusies, Overnames

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- WSJ

DJ

Lezen

16 dec 2025, 20:54 UTC

Acquisities, Fusies, Overnames

Warner to Recommend Existing Netflix Deal, Sources Say -- WSJ

DJ

Lezen

16 dec 2025, 20:44 UTC

Marktinformatie

Russia-Ukraine Peace Efforts Send Crude to Near 5-Year Low -- Market Talk

DJ

Lezen

16 dec 2025, 20:04 UTC

Marktinformatie

U.S. Natural Gas Extends Weather-Driven Losing Streak -- Market Talk

DJ

Lezen

16 dec 2025, 20:01 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

Peer Vergelijking

Prijswijziging

Pulse Biosciences Inc Prognose

Koersdoel

By TipRanks

54.6% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 22 USD  54.6%

Hoogste 22 USD

Laagste 22 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pulse Biosciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Pulse Biosciences Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

16.59 / 17.17Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Bearish Evidence

Recent bearish events outweigh bullish events.

Lange Termijn

Weak Bearish Evidence

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

97 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,042.17

↓-0.56%

JNJ

Johnson and Johnson

210.98

↑ +0.88%

ABBV

AbbVie Inc

224.84

↑ +0.63%

UNH

UnitedHealth Group Inc

331.47

↓-0.62%

AZN

AstraZeneca PLC ADR

90.05

↓-1.5%
help-icon Live chat